Targeting of others transcription factors such as GLI (Moshai et al., 2014), FOXM1 (Penke et al., 2018), FOXF1 (Black et al., 2018), FOXO3 (Al-Tamari et al., 2018), RUNX2 (Mümmler et al., 2018), and TBX4 (Xie et al., 2016) was also shown to inhibit fibrosis development in this mouse experimental model of pulmonary fibrosis. Here, RUNX2 is linked to pulmonary fibrosis.